Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Formulation Development Pre-formulation Studies

Posted on By

SOP for Formulation Development Pre-formulation Studies

Conducting Pre-formulation Studies for Formulation Development

1) Purpose

The purpose of this SOP is to outline the procedure for conducting pre-formulation studies during the formulation development process, aiming to gather critical information about the physical and chemical properties of the active pharmaceutical ingredient (API) and excipients.

2) Scope

This SOP applies to all formulation development projects within the organization, covering the entire pre-formulation study process from initial testing to final documentation.

3) Responsibilities

The responsibilities for this SOP include:
Project Manager: Overseeing the pre-formulation study process and ensuring alignment with project objectives.
Team Members: Conducting the pre-formulation tests and analyzing the results.
Quality Assurance: Reviewing and approving the pre-formulation study documentation.

See also  SOP for Formulation Development Documentation Management

4) Procedure

4.1 Planning Pre-formulation Studies

  1. Define the objectives and scope of the pre-formulation studies.
  2. Select the API and excipients to be tested.
  3. Develop a pre-formulation study plan, including testing methods and conditions.
  4. Document the pre-formulation study plan.

4.2 Physical Characterization of API and Excipients

  1. Determine the physical properties of the API and excipients, including:
    1. Particle size and distribution
    2. Solubility and dissolution rate
    3. Hygroscopicity
    4. Polymorphism
    5. Melting point and thermal behavior
  2. Document the physical characterization data.

4.3 Chemical Characterization of API and Excipients

  1. Determine the chemical properties of the API and excipients, including:
    1. pH and pKa
    2. Partition coefficient
    3. Stability in various conditions (e.g., temperature, humidity,
light)
  • Potential for chemical interactions
  • Document the chemical characterization data.
  • 4.4 Compatibility Studies

    1. Conduct compatibility studies to assess the interaction between the API and selected excipients.
    2. Evaluate the stability and performance of the API-excipient combinations under various conditions.
    3. Document the results of the compatibility studies in a compatibility assessment report.

    4.5 Data Analysis and Interpretation

    1. Analyze the test data to determine the suitability of the API and excipients for the intended formulation.
    2. Interpret the results to identify any potential stability issues or interactions.
    3. Document the analysis and interpretation in a pre-formulation study report.

    4.6 Approval and Documentation

    1. Submit the pre-formulation study report to senior management and quality assurance for review.
    2. Obtain formal approval from senior management and quality assurance.
    3. Ensure all documentation related to the pre-formulation studies is complete and accurate.
    4. Store the documentation in accordance with organizational record-keeping policies.

    5) Abbreviations, if any

    API: Active Pharmaceutical Ingredient
    SOP: Standard Operating Procedure
    pKa: Acid dissociation constant

    6) Documents, if any

    Pre-formulation Study Plan
    Physical Characterization Data
    Chemical Characterization Data
    Compatibility Assessment Report
    Pre-formulation Study Report

    7) Reference, if any

    – ICH Q8: Pharmaceutical Development
    – FDA Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations

    8) SOP Version

    Version 1.0

    See also  SOP for Formulation Development Technology Transfer
    Formulation Development Tags:API selection SOP, Batch record SOP, Change control SOP, Cleaning Validation SOP, Clinical trial material SOP, Deviation handling SOP, Drug formulation procedure, Equipment Qualification SOP, Excipient selection SOP, Formulation development SOP, Formulation process SOP, GMP SOP, Pharmaceutical SOP, Process Validation SOP, Quality by design SOP, Regulatory submission SOP, Risk assessment SOP, SOP for drug development, SOP for stability testing, SOP guidelines pharmaceutical, SOP pharmaceutical industry, SOP template for formulation, Standard operating procedure formulation, Technology transfer SOP, Validation SOP

    Post navigation

    Previous Post: SOP for Preventive Maintenance of HVAC Filters
    Next Post: SOP for Analytical Method Development Feasibility Studies

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version